Dexcom (DXCM) Cash & Equivalents Growth (1y) (2011 - 2026)
Dexcom (DXCM) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 72.43% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -26.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.66% |
| Mar 31, 2026 | 23.57% |
| Dec 31, 2025 | 583.83% |
| Sep 30, 2025 | 121.06% |
| Jun 30, 2025 | 23.40% |
| Mar 31, 2025 | 6.31% |
| Dec 31, 2024 | -76.30% |
| Sep 30, 2024 | -3.50% |
| Jun 30, 2024 | -21.40% |
| Mar 31, 2024 | 36.59% |
| Dec 31, 2023 | -11.83% |
| Sep 30, 2023 | -7.79% |
| Jun 30, 2023 | 62.48% |
| Mar 31, 2023 | -12.96% |
| Dec 31, 2022 | -38.98% |
| Sep 30, 2022 | -51.67% |
| Jun 30, 2022 | -36.54% |
| Mar 31, 2022 | -2.43% |
| Dec 31, 2021 | 28.74% |
| Sep 30, 2021 | 114.45% |